Impacto de la intervención farmacéutica en la adherencia al tratamiento antirretroviral en pacientes de un hospital de Lima (Perú).
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Tafur Valderrama, E.J.Ortiz Alfaro, C.
García-Jiménez, E.
Faus Dader, M.J.
Martínez Martínez, F.
Issue Date
2014-03-20Keywords
Adherencia al tratamientotratamiento antirretroviral
seguimiento farmacoterapéutico
VIH/sida
Medication adherence
antiretroviral therapy
highly active
pharmaceutical care
HIV/AIDS
Metadata
Show full item recordOther Titles
Pharmacist intervention in the improvement of adherence in HIV/AIDS patients with antiretroviral treatment in Lima (Peru).Citation
Pharm Care Esp. 2012; 14(4): 146-154Publisher
Fundación Pharmaceutical Care EspañaAdditional Links
http://www.pharmcareesp.com/index.php/PharmaCARE/article/view/81/75Abstract
Introduction: Pharmaceutical care improves medication adherence that is why is important that the pharmacist uses instruments to evaluate and improves it through pharmaceutical intervention at pharmaceutical care. Objective: To evaluate the impact of the pharmaceutical intervention in the improvement of the medication adherence of the patients with HIV and AIDS, and to identify the factors that infl uence on medication adherence and which one could be modifi ed by the pharmaceutical intervention during pharmaceutical care. Methods: Pharmacotherapeutic follow-up was realized for 23 months to 52 patients, older than 18 years, with antiretroviral treatment for up to three months, consent informed was obtained from patients. Medication adherence was evaluated with CEAT-HIV (questionnaire to evaluate the adhesion to the antiretroviral treatment) at the beginning and at the end of the study (6 months). Results: The fi nal score from CEAT-HIV (p <0.05; 95% IC), treatment compliance (p <0.001) and patient’s beliefs to the disease and antiretroviral treatment (p <0.001) improved signifi cantly with the pharmaceutical intervention. The more frequent pharmaceutical intervention was education to the patient to increment the adherence to the treatment (46%). Conclusion: These results demonstrate that the pharmacists’ intervention through pharmacotherapeutic follow-up improves the adherence to the antiretroviral treatment. The pharmacist was able to improve aspects of compliance and patient’s beliefs about the treatment and disease. The pharmacist could utilize CEAT-VIH as an instrument to evaluate the adherence in HIV/AIDS patients.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/openAccessLanguage
spaISSN
1139-6202Collections